Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Endothelial Function in Alzheimer's Disease by 18kDa Translocator Protein

NCT07191821 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT07191821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07191821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Endothelial Function in Alzheimer's Disease by 18kDa Translocator Protein
Lead sponsor
Imperial College London
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
August 8, 2025
Completion date
June 1, 2027
Enrollment
51 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer s disease